Spectral AI Inc Ordinary Shares - Class A MDAI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites
-
Spectral AI Outlines U.S. Regulatory Pathway for DeepView® System for Burn Indication
-
American Burn Association Study Highlights Inequities in Access to Specialized Burn Care
-
Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®
-
Spectral AI to Participate in Upcoming Investor Conferences
-
Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study
-
Spectral AI Announces Podium Presentation at BBA / ISBI Joint Conference Assessing Burn Wound Severity Using Multispectral Imaging and Artificial Intelligence
-
Spectral AI Announces 2024 Second Quarter Financial Results
Trading Information
- Previous Close Price
- $0.95
- Day Range
- $0.96–1.14
- 52-Week Range
- $0.82–4.68
- Bid/Ask
- $1.14 / $1.19
- Market Cap
- $19.72 Mil
- Volume/Avg
- 577,438 / 209,243
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.73
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient’s wound.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- 78
- Website
- https://www.spectralmd.com
Valuation
|
Metric
|
MDAI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.73 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MDAI
|
|---|---|
Quick Ratio | 0.57 |
Current Ratio | 0.72 |
Interest Coverage | — |
Quick Ratio
MDAI
Profitability
|
Metric
|
MDAI
|
|---|---|
Return on Assets (Normalized) | −105.87% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −426.15% |
Return on Assets
MDAI
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Cwwzqgj | Qhxwym | $196.1 Bil | |||
| Stryker Corp
SYK
| Zkfbsvbdld | Ztrgc | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Yvtmbqc | Wnqgxbm | $122.3 Bil | |||
| Medtronic PLC
MDT
| Klsxkvkzm | Pvctsmm | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Fkkvgrnxw | Fycjgf | $39.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Dpsm | Rxtx | $29.1 Bil | |||
| DexCom Inc
DXCM
| Gnkcthzgf | Vvzh | $27.1 Bil | |||
| Steris PLC
STE
| Bsmpnlkls | Rysjty | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Wzwhyymvjz | Lyp | $21.9 Bil | |||
| Insulet Corp
PODD
| Yymffhjzn | Fszwdx | $16.5 Bil |
United States